ID   RPB7_HUMAN              Reviewed;         172 AA.
AC   P62487; B2R5C0; P52433; Q2M1Z4;
DT   19-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   19-JUL-2004, sequence version 1.
DT   15-MAR-2017, entry version 129.
DE   RecName: Full=DNA-directed RNA polymerase II subunit RPB7;
DE            Short=RNA polymerase II subunit B7;
DE   AltName: Full=DNA-directed RNA polymerase II subunit G;
DE   AltName: Full=RNA polymerase II 19 kDa subunit;
DE            Short=RPB19;
GN   Name=POLR2G; Synonyms=RPB7;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=7579693; DOI=10.1091/mbc.6.7.759;
RA   Khazak V., Sadhale P.P., Woychik N.A., Brent R., Golemis E.A.;
RT   "Human RNA polymerase II subunit hsRPB7 functions in yeast and
RT   influences stress survival and cell morphology.";
RL   Mol. Biol. Cell 6:759-775(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9256063; DOI=10.1016/S0167-4781(97)00041-9;
RA   Schoen T.J., Chandrasekharappa S.C., Guru S.C., Mazuruk K.,
RA   Chader G.J., Rodriguez I.R.;
RT   "Human gene for the RNA polymerase II seventh subunit (hsRPB7):
RT   structure, expression and chromosomal localization.";
RL   Biochim. Biophys. Acta 1353:39-49(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION, IDENTIFICATION IN THE RNA POLYMERASE II CORE-COMPLEX, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=9852112; DOI=10.1074/jbc.273.51.34444;
RA   Kershnar E., Wu S.-Y., Chiang C.-M.;
RT   "Immunoaffinity purification and functional characterization of human
RT   transcription factor IIH and RNA polymerase II from clonal cell lines
RT   that conditionally express epitope-tagged subunits of the multiprotein
RT   complexes.";
RL   J. Biol. Chem. 273:34444-34453(1998).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF THE POL II RPB4-RPB7
RP   SUBCOMPLEX, RNA-BINDING, AND MUTAGENESIS OF HIS-14; GLU-33; LYS-41;
RP   THR-90; ASN-93; LYS-94; PHE-107; SER-109; HIS-111; ARG-151; ASP-153
RP   AND PHE-158.
RX   PubMed=16282592; DOI=10.1093/nar/gki945;
RA   Meka H., Werner F., Cordell S.C., Onesti S., Brick P.;
RT   "Crystal structure and RNA binding of the Rpb4/Rpb7 subunits of human
RT   RNA polymerase II.";
RL   Nucleic Acids Res. 33:6435-6444(2005).
CC   -!- FUNCTION: DNA-dependent RNA polymerase catalyzes the transcription
CC       of DNA into RNA using the four ribonucleoside triphosphates as
CC       substrates. Component of RNA polymerase II which synthesizes mRNA
CC       precursors and many functional non-coding RNAs. Pol II is the
CC       central component of the basal RNA polymerase II transcription
CC       machinery. It is composed of mobile elements that move relative to
CC       each other. RPB7 is part of a subcomplex with RPB4 that binds to a
CC       pocket formed by RPB1, RPB2 and RPB6 at the base of the clamp
CC       element. The RBP4-RPB7 subcomplex seems to lock the clamp via RPB7
CC       in the closed conformation thus preventing double-stranded DNA to
CC       enter the active site cleft. The RPB4-RPB7 subcomplex binds
CC       single-stranded DNA and RNA (By similarity). Binds RNA.
CC       {ECO:0000250, ECO:0000269|PubMed:9852112}.
CC   -!- SUBUNIT: Component of the RNA polymerase II (Pol II) complex
CC       consisting of 12 subunits. RPB4 and RPB7 form a subcomplex that
CC       protrudes from the 10-subunit Pol II core complex.
CC       {ECO:0000269|PubMed:9852112}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:9852112}.
CC   -!- SIMILARITY: Belongs to the eukaryotic RPB7/RPC8 RNA polymerase
CC       subunit family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U20659; AAA86500.1; -; mRNA.
DR   EMBL; U52427; AAB96827.1; -; Genomic_DNA.
DR   EMBL; AK312131; BAG35067.1; -; mRNA.
DR   EMBL; CH471076; EAW74092.1; -; Genomic_DNA.
DR   EMBL; BC112162; AAI12163.1; -; mRNA.
DR   EMBL; BC112164; AAI12165.1; -; mRNA.
DR   CCDS; CCDS31585.1; -.
DR   RefSeq; NP_002687.1; NM_002696.2.
DR   UniGene; Hs.14839; -.
DR   PDB; 2C35; X-ray; 2.70 A; B/D/F/H=1-172.
DR   PDB; 5IY6; EM; 7.20 A; G=1-172.
DR   PDB; 5IY7; EM; 8.60 A; G=1-172.
DR   PDB; 5IY8; EM; 7.90 A; G=1-172.
DR   PDB; 5IY9; EM; 6.30 A; G=1-172.
DR   PDB; 5IYA; EM; 5.40 A; G=1-172.
DR   PDB; 5IYB; EM; 3.90 A; G=1-172.
DR   PDB; 5IYC; EM; 3.90 A; G=1-172.
DR   PDB; 5IYD; EM; 3.90 A; G=1-172.
DR   PDBsum; 2C35; -.
DR   PDBsum; 5IY6; -.
DR   PDBsum; 5IY7; -.
DR   PDBsum; 5IY8; -.
DR   PDBsum; 5IY9; -.
DR   PDBsum; 5IYA; -.
DR   PDBsum; 5IYB; -.
DR   PDBsum; 5IYC; -.
DR   PDBsum; 5IYD; -.
DR   ProteinModelPortal; P62487; -.
DR   SMR; P62487; -.
DR   BioGrid; 111432; 92.
DR   DIP; DIP-32663N; -.
DR   IntAct; P62487; 67.
DR   MINT; MINT-1033626; -.
DR   STRING; 9606.ENSP00000301788; -.
DR   iPTMnet; P62487; -.
DR   PhosphoSitePlus; P62487; -.
DR   BioMuta; POLR2G; -.
DR   DMDM; 50403601; -.
DR   EPD; P62487; -.
DR   MaxQB; P62487; -.
DR   PaxDb; P62487; -.
DR   PeptideAtlas; P62487; -.
DR   PRIDE; P62487; -.
DR   Ensembl; ENST00000301788; ENSP00000301788; ENSG00000168002.
DR   GeneID; 5436; -.
DR   KEGG; hsa:5436; -.
DR   UCSC; uc001nva.4; human.
DR   CTD; 5436; -.
DR   DisGeNET; 5436; -.
DR   GeneCards; POLR2G; -.
DR   HGNC; HGNC:9194; POLR2G.
DR   HPA; HPA053000; -.
DR   MIM; 602013; gene.
DR   neXtProt; NX_P62487; -.
DR   OpenTargets; ENSG00000168002; -.
DR   PharmGKB; PA33514; -.
DR   eggNOG; KOG3298; Eukaryota.
DR   eggNOG; COG1095; LUCA.
DR   GeneTree; ENSGT00390000008975; -.
DR   HOGENOM; HOG000158201; -.
DR   HOVERGEN; HBG055233; -.
DR   InParanoid; P62487; -.
DR   KO; K03015; -.
DR   OMA; SYFGPRM; -.
DR   OrthoDB; EOG091G0MF6; -.
DR   PhylomeDB; P62487; -.
DR   TreeFam; TF103042; -.
DR   Reactome; R-HSA-112382; Formation of RNA Pol II elongation complex.
DR   Reactome; R-HSA-112387; Elongation arrest and recovery.
DR   Reactome; R-HSA-113418; Formation of the Early Elongation Complex.
DR   Reactome; R-HSA-167152; Formation of HIV elongation complex in the absence of HIV Tat.
DR   Reactome; R-HSA-167158; Formation of the HIV-1 Early Elongation Complex.
DR   Reactome; R-HSA-167160; RNA Pol II CTD phosphorylation and interaction with CE during HIV infection.
DR   Reactome; R-HSA-167161; HIV Transcription Initiation.
DR   Reactome; R-HSA-167162; RNA Polymerase II HIV Promoter Escape.
DR   Reactome; R-HSA-167172; Transcription of the HIV genome.
DR   Reactome; R-HSA-167200; Formation of HIV-1 elongation complex containing HIV-1 Tat.
DR   Reactome; R-HSA-167238; Pausing and recovery of Tat-mediated HIV elongation.
DR   Reactome; R-HSA-167242; Abortive elongation of HIV-1 transcript in the absence of Tat.
DR   Reactome; R-HSA-167243; Tat-mediated HIV elongation arrest and recovery.
DR   Reactome; R-HSA-167246; Tat-mediated elongation of the HIV-1 transcript.
DR   Reactome; R-HSA-167287; HIV elongation arrest and recovery.
DR   Reactome; R-HSA-167290; Pausing and recovery of HIV elongation.
DR   Reactome; R-HSA-168325; Viral Messenger RNA Synthesis.
DR   Reactome; R-HSA-203927; MicroRNA (miRNA) biogenesis.
DR   Reactome; R-HSA-452723; Transcriptional regulation of pluripotent stem cells.
DR   Reactome; R-HSA-5578749; Transcriptional regulation by small RNAs.
DR   Reactome; R-HSA-5601884; PIWI-interacting RNA (piRNA) biogenesis.
DR   Reactome; R-HSA-5617472; Activation of anterior HOX genes in hindbrain development during early embryogenesis.
DR   Reactome; R-HSA-674695; RNA Polymerase II Pre-transcription Events.
DR   Reactome; R-HSA-6781823; Formation of TC-NER Pre-Incision Complex.
DR   Reactome; R-HSA-6781827; Transcription-Coupled Nucleotide Excision Repair (TC-NER).
DR   Reactome; R-HSA-6782135; Dual incision in TC-NER.
DR   Reactome; R-HSA-6782210; Gap-filling DNA repair synthesis and ligation in TC-NER.
DR   Reactome; R-HSA-6796648; TP53 Regulates Transcription of DNA Repair Genes.
DR   Reactome; R-HSA-6803529; FGFR2 alternative splicing.
DR   Reactome; R-HSA-6807505; RNA polymerase II transcribes snRNA genes.
DR   Reactome; R-HSA-72086; mRNA Capping.
DR   Reactome; R-HSA-72163; mRNA Splicing - Major Pathway.
DR   Reactome; R-HSA-72165; mRNA Splicing - Minor Pathway.
DR   Reactome; R-HSA-72203; Processing of Capped Intron-Containing Pre-mRNA.
DR   Reactome; R-HSA-73776; RNA Polymerase II Promoter Escape.
DR   Reactome; R-HSA-73779; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening.
DR   Reactome; R-HSA-75953; RNA Polymerase II Transcription Initiation.
DR   Reactome; R-HSA-75955; RNA Polymerase II Transcription Elongation.
DR   Reactome; R-HSA-76042; RNA Polymerase II Transcription Initiation And Promoter Clearance.
DR   Reactome; R-HSA-77075; RNA Pol II CTD phosphorylation and interaction with CE.
DR   Reactome; R-HSA-8851708; Signaling by FGFR2 IIIa TM.
DR   ChiTaRS; POLR2G; human.
DR   EvolutionaryTrace; P62487; -.
DR   GeneWiki; POLR2G; -.
DR   GenomeRNAi; 5436; -.
DR   PRO; PR:P62487; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000168002; -.
DR   CleanEx; HS_POLR2G; -.
DR   ExpressionAtlas; P62487; baseline and differential.
DR   Genevisible; P62487; HS.
DR   GO; GO:0005665; C:DNA-directed RNA polymerase II, core complex; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0000932; C:P-body; IBA:GO_Central.
DR   GO; GO:0003899; F:DNA-directed 5'-3' RNA polymerase activity; IEA:UniProtKB-KW.
DR   GO; GO:0003697; F:single-stranded DNA binding; IBA:GO_Central.
DR   GO; GO:0003727; F:single-stranded RNA binding; IBA:GO_Central.
DR   GO; GO:0031369; F:translation initiation factor binding; IBA:GO_Central.
DR   GO; GO:0006370; P:7-methylguanosine mRNA capping; TAS:Reactome.
DR   GO; GO:0006915; P:apoptotic process; IEA:Ensembl.
DR   GO; GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0010467; P:gene expression; TAS:Reactome.
DR   GO; GO:0031047; P:gene silencing by RNA; TAS:Reactome.
DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome.
DR   GO; GO:0000291; P:nuclear-transcribed mRNA catabolic process, exonucleolytic; IBA:GO_Central.
DR   GO; GO:0060213; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; IBA:GO_Central.
DR   GO; GO:0045948; P:positive regulation of translational initiation; IBA:GO_Central.
DR   GO; GO:0050434; P:positive regulation of viral transcription; TAS:Reactome.
DR   GO; GO:0042795; P:snRNA transcription from RNA polymerase II promoter; TAS:Reactome.
DR   GO; GO:0035019; P:somatic stem cell population maintenance; TAS:Reactome.
DR   GO; GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome.
DR   GO; GO:0006366; P:transcription from RNA polymerase II promoter; IDA:UniProtKB.
DR   GO; GO:0006367; P:transcription initiation from RNA polymerase II promoter; IBA:GO_Central.
DR   GO; GO:0006283; P:transcription-coupled nucleotide-excision repair; TAS:Reactome.
DR   Gene3D; 3.30.1490.120; -; 1.
DR   InterPro; IPR012340; NA-bd_OB-fold.
DR   InterPro; IPR005576; RNA_pol_Rpb7_N.
DR   InterPro; IPR022967; S1_dom.
DR   InterPro; IPR003029; S1_domain.
DR   Pfam; PF00575; S1; 1.
DR   Pfam; PF03876; SHS2_Rpb7-N; 1.
DR   SMART; SM00316; S1; 1.
DR   SUPFAM; SSF50249; SSF50249; 1.
DR   SUPFAM; SSF88798; SSF88798; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; DNA-directed RNA polymerase; Nucleus;
KW   Reference proteome; RNA-binding; Transcription.
FT   CHAIN         1    172       DNA-directed RNA polymerase II subunit
FT                                RPB7.
FT                                /FTId=PRO_0000073986.
FT   MUTAGEN      14     14       H->E: Strongly reduces RNA-binding.
FT                                {ECO:0000269|PubMed:16282592}.
FT   MUTAGEN      33     33       E->K: Strongly reduces RNA-binding.
FT                                {ECO:0000269|PubMed:16282592}.
FT   MUTAGEN      41     41       K->E: Strongly reduces RNA-binding.
FT                                {ECO:0000269|PubMed:16282592}.
FT   MUTAGEN      90     90       T->A: Reduces RNA-binding.
FT                                {ECO:0000269|PubMed:16282592}.
FT   MUTAGEN      93     93       N->A: Reduces RNA-binding.
FT                                {ECO:0000269|PubMed:16282592}.
FT   MUTAGEN      94     94       K->E: Reduces RNA-binding.
FT                                {ECO:0000269|PubMed:16282592}.
FT   MUTAGEN     107    107       F->E: Reduces RNA-binding.
FT                                {ECO:0000269|PubMed:16282592}.
FT   MUTAGEN     109    109       S->A: Strongly reduces RNA-binding.
FT                                {ECO:0000269|PubMed:16282592}.
FT   MUTAGEN     111    111       H->E: Strongly reduces RNA-binding.
FT                                {ECO:0000269|PubMed:16282592}.
FT   MUTAGEN     151    151       R->E: Strongly reduces RNA-binding.
FT                                {ECO:0000269|PubMed:16282592}.
FT   MUTAGEN     153    153       D->E: Strongly reduces RNA-binding.
FT                                {ECO:0000269|PubMed:16282592}.
FT   MUTAGEN     158    158       F->A: Strongly reduces RNA-binding.
FT                                {ECO:0000269|PubMed:16282592}.
FT   STRAND        2     13       {ECO:0000244|PDB:2C35}.
FT   HELIX        15     17       {ECO:0000244|PDB:2C35}.
FT   HELIX        22     34       {ECO:0000244|PDB:2C35}.
FT   TURN         40     42       {ECO:0000244|PDB:2C35}.
FT   STRAND       43     54       {ECO:0000244|PDB:2C35}.
FT   STRAND       64     77       {ECO:0000244|PDB:2C35}.
FT   STRAND       84     93       {ECO:0000244|PDB:2C35}.
FT   STRAND       96    101       {ECO:0000244|PDB:2C35}.
FT   STRAND      104    109       {ECO:0000244|PDB:2C35}.
FT   HELIX       110    112       {ECO:0000244|PDB:2C35}.
FT   STRAND      117    125       {ECO:0000244|PDB:2C35}.
FT   STRAND      127    130       {ECO:0000244|PDB:2C35}.
FT   STRAND      135    138       {ECO:0000244|PDB:2C35}.
FT   STRAND      142    153       {ECO:0000244|PDB:2C35}.
FT   STRAND      156    162       {ECO:0000244|PDB:2C35}.
SQ   SEQUENCE   172 AA;  19294 MW;  AF3CE655F658CD5C CRC64;
     MFYHISLEHE ILLHPRYFGP NLLNTVKQKL FTEVEGTCTG KYGFVIAVTT IDNIGAGVIQ
     PGRGFVLYPV KYKAIVFRPF KGEVVDAVVT QVNKVGLFTE IGPMSCFISR HSIPSEMEFD
     PNSNPPCYKT MDEDIVIQQD DEIRLKIVGT RVDKNDIFAI GSLMDDYLGL VS
//
